Literature DB >> 31744778

Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.

Anand S Chintakrindi1, Devanshi J Gohil2, Abhay S Chowdhary2, Meena A Kanyalkar3.   

Abstract

We designed a series of substituted flavones and aurones as non-competitive H1N1 neuraminidase (NA) inhibitors and anti-influenza agents. The molecular docking studies showed that the designed flavones and aurones occupied 150-cavity and 430-cavity of H1N1-NA. We then synthesized these compounds and evaluated these for cytotoxicity, reduction in H1N1 virus yield, H1N1-NA inhibition and kinetics of inhibition. The virus yield reduction assay and H1N1-NA inhibition assay demonstrated that the compound 1f (4-methoxyflavone) had the lowest EC50 of 9.36 nM and IC50 of 8.74 μM respectively. Moreover, kinetic studies illustrated that compounds 1f and 2f had non-competitive inhibition mechanism.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aurones; Flavone; H1N1; Influenza; Neuraminidase; Non-competitive

Mesh:

Substances:

Year:  2019        PMID: 31744778     DOI: 10.1016/j.bmc.2019.115191

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  2-Benzylidenebenzofuran-3(2H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies.

Authors:  Jamshaid Ashraf; Ehsan Ullah Mughal; Reem I Alsantali; Amina Sadiq; Rabab S Jassas; Nafeesa Naeem; Zaman Ashraf; Yasir Nazir; Muhammad Naveed Zafar; Amara Mumtaz; Masoud Mirzaei; Satar Saberi; Saleh A Ahmed
Journal:  RSC Adv       Date:  2021-10-29       Impact factor: 4.036

2.  Structure-based design of 5'-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors.

Authors:  Pengfei Wang; Babayemi O Oladejo; Chenning Li; Lifeng Fu; Shanshan Zhang; Jianxun Qi; Xun Lv; Xuebing Li
Journal:  RSC Adv       Date:  2021-03-03       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.